Quantum BioPharma Ltd. Adjustments For Finance Income
Quantum BioPharma Ltd. (QNTM) reported Adjustments For Finance Income of -$1.49 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFinanceIncome · last filed 2026-03-26
- Quantum BioPharma Ltd. adjustments for finance income for the quarter ending 2025-12-31 was -$916.73K.
- Quantum BioPharma Ltd. adjustments for finance income for the quarter ending 2025-09-30 was -$180.79K, a 135.64% decline year-over-year.
- Quantum BioPharma Ltd. adjustments for finance income for the quarter ending 2025-06-30 was $20.71K.
- Quantum BioPharma Ltd. adjustments for finance income for the quarter ending 2025-03-31 was -$414.19K.
| Period end | Adjustments For Finance Income 3 month | Adjustments For Finance Income 6 month | Adjustments For Finance Income 6 month as first filed | Adjustments For Finance Income 9 month | Adjustments For Finance Income 9 month as first filed | Adjustments For Finance Income 12 month | Adjustments For Finance Income 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$916.73K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$1.10M derived: sum of 2 quarters · filed 2026-03-26 | -$1.08M derived: sum of 3 quarters · filed 2026-03-26 | -$1.49M 20-F · filed 2026-03-26 | |||
| 2025-09-30 | -$180.79K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$160.09K derived: sum of 2 quarters · filed 2025-11-06 | -$574.27K 6-K · filed 2025-11-06 | -$4.13M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2025-06-30 | $20.71K derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$393.48K 6-K · filed 2025-08-07 | -$3.94M derived: sum of 3 quarters · filed 2026-03-26 | -$3.44M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2025-03-31 | -$414.19K 6-K/A · filed 2025-06-16 | -$3.97M derived: sum of 2 quarters · filed 2026-03-26 | -$3.46M derived: sum of 3 quarters · filed 2026-03-26 | -$4.53M derived: sum of 4 quarters · filed 2026-03-26 | |||
| 2024-12-31 | -$3.55M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | -$3.04M derived: sum of 2 quarters · filed 2026-03-26 | -$4.11M derived: sum of 3 quarters · filed 2026-03-26 | -$4.66M 20-F · filed 2026-03-26 | $4.66M 20-F · filed 2025-03-28 | ||
| 2024-09-30 | $507.31K derived: 6-K 9 month − 6-K 6 month · filed 2025-11-06 | -$563.29K derived: sum of 2 quarters · filed 2025-11-06 | -$1.11M 6-K · filed 2025-11-06 | $1.11M 6-K · filed 2024-11-12 | -$1.08M derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-06-30 | -$1.07M derived: 6-K 6 month − 6-K/A 3 month · filed 2025-08-07 | -$1.62M 6-K · filed 2025-08-07 | $1.62M 6-K/A · filed 2024-08-19 | -$1.59M derived: sum of 3 quarters · filed 2026-03-26 | -$59.02K derived: sum of 4 quarters · filed 2026-03-26 | ||
| 2024-03-31 | -$548.55K 6-K/A · filed 2025-06-16 | -$518.93K derived: sum of 2 quarters · filed 2026-03-26 | $1.01M derived: sum of 3 quarters · filed 2026-03-26 | ||||
| 2023-12-31 | $29.62K derived: 20-F 12 month − 6-K 9 month · filed 2026-03-26 | $1.56M derived: sum of 2 quarters · filed 2026-03-26 | $663.70K 20-F · filed 2026-03-26 | ||||
| 2023-09-30 | $1.53M derived: 6-K 9 month − 6-K/A 6 month · filed 2024-11-12 | $634.08K 6-K · filed 2024-11-12 | |||||
| 2023-06-30 | -$896.43K 6-K/A · filed 2024-08-19 | ||||||
| 2022-12-31 | $7.43M 20-F/A · filed 2025-03-31 | ||||||
| 2021-12-31 | $0.00 20-F · filed 2024-04-02 | ||||||
| 2020-12-31 | $0.00 20-F · filed 2023-03-31 |